Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Purchase | 2024-12-18 4:00 pm | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 30,000 | $1.03 | $30,900 | 164,578 (Direct) | View |
| 2023-08-25 Purchase | 2023-08-29 4:08 pm | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 4,000 | $2.76 | $11,040 | 135,638 (Direct) | View |
| 2023-08-14 Purchase | 2023-08-16 4:07 pm | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 3,000 | $2.86 | $8,580 | 134,578 (Direct) | View |
| 2023-03-23 Sale | 2023-03-27 4:05 pm | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,325 | $3.28 | $30,586 | 96,419 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Option Award | 2024-11-29 4:00 pm | N/A 2034-11-24 | Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 4:00 pm | N/A 2034-09-02 | Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Fox Michael J Director | 48,800 | $0 | 48,800 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2024-06-07 4:00 pm | N/A N/A | Cue Biopharma Inc. | CUE | Fox Michael J Director | 0 | $0 | 1,100,000 (Indirect) | View |
| 2024-06-05 Option Award | 2024-06-07 4:00 pm | N/A 2034-06-04 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 260,000 | $0 | 260,000 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:00 pm | N/A 2033-01-16 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:01 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:00 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Morich Frank Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:33 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 82,500 | $0 | 82,500 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:31 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 113,000 | $0 | 113,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:28 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:27 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:25 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 124,125 | $0 | 124,125 (Direct) | View |
| 2023-04-19 Option Award | 2023-04-21 4:15 pm | N/A 2033-04-18 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-04-13 4:43 pm | N/A N/A | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 0 | $0 | 8,174 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-13 4:42 pm | N/A 2033-04-10 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-03-23 Exercise | 2023-03-27 4:05 pm | N/A N/A | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,682 | $2.86 | 96,419 (Direct) | View |
| 2023-03-23 Exercise | 2023-03-27 4:05 pm | N/A 2023-03-23 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,682 | $0 | 96,419 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:03 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | NASSHORN PATRICIA Chief Business Officer | 97,900 | $0 | 97,900 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:01 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 125,500 | $0 | 125,500 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:00 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:59 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 324,000 | $0 | 324,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:58 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 124,000 | $0 | 124,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:02 pm | N/A 2033-01-16 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |